Schwab Charles Investment Management Inc. lifted its position in MAXIMUS, Inc. (NYSE:MMS) by 5.3% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 726,384 shares of the health services provider’s stock after purchasing an additional 36,570 shares during the period. Schwab Charles Investment Management Inc. owned 1.12% of MAXIMUS worth $51,995,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. Public Employees Retirement System of Ohio increased its position in shares of MAXIMUS by 0.3% in the 2nd quarter. Public Employees Retirement System of Ohio now owns 73,252 shares of the health services provider’s stock valued at $4,588,000 after acquiring an additional 207 shares during the period. Stifel Financial Corp grew its position in MAXIMUS by 5.2% during the 2nd quarter. Stifel Financial Corp now owns 9,186 shares of the health services provider’s stock worth $576,000 after purchasing an additional 455 shares during the period. Ameritas Investment Partners Inc. grew its position in MAXIMUS by 2.1% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 25,038 shares of the health services provider’s stock worth $1,568,000 after purchasing an additional 517 shares during the period. Cubist Systematic Strategies LLC grew its position in MAXIMUS by 16.0% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after purchasing an additional 546 shares during the period. Finally, UBS Asset Management Americas Inc. grew its position in MAXIMUS by 1.7% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 34,898 shares of the health services provider’s stock worth $2,186,000 after purchasing an additional 592 shares during the period. Institutional investors own 95.55% of the company’s stock.
In other news, General Counsel David Francis sold 1,373 shares of the company’s stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $65.35, for a total value of $89,725.55. Following the completion of the sale, the general counsel now directly owns 13,617 shares of the company’s stock, valued at $889,870.95. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Richard A. Montoni sold 30,000 shares of the business’s stock in a transaction dated Thursday, December 7th. The stock was sold at an average price of $69.25, for a total transaction of $2,077,500.00. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 69,617 shares of company stock valued at $4,789,052. Corporate insiders own 2.48% of the company’s stock.
A number of research firms have recently commented on MMS. Zacks Investment Research upgraded MAXIMUS from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research report on Tuesday. Canaccord Genuity decreased their price target on shares of MAXIMUS from $71.00 to $65.00 and set a “hold” rating on the stock in a research note on Friday, February 9th. Finally, Maxim Group reissued a “hold” rating and issued a $69.00 target price (up from $66.00) on shares of MAXIMUS in a research note on Thursday, February 8th. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $66.60.
MAXIMUS, Inc. (NYSE:MMS) traded up $1.13 during trading on Wednesday, reaching $66.42. 306,687 shares of the company traded hands, compared to its average volume of 513,621. MAXIMUS, Inc. has a 12-month low of $57.12 and a 12-month high of $72.71. The company has a debt-to-equity ratio of 0.01, a current ratio of 2.57 and a quick ratio of 2.57. The firm has a market cap of $4,203.65, a P/E ratio of 19.45, a PEG ratio of 2.14 and a beta of 1.21.
MAXIMUS (NYSE:MMS) last posted its quarterly earnings results on Thursday, February 8th. The health services provider reported $0.78 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.77 by $0.01. The business had revenue of $623.10 million during the quarter, compared to the consensus estimate of $624.36 million. MAXIMUS had a net margin of 8.99% and a return on equity of 22.93%. The company’s quarterly revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.71 earnings per share. research analysts predict that MAXIMUS, Inc. will post 3.44 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, February 28th. Stockholders of record on Thursday, February 15th will be given a dividend of $0.045 per share. The ex-dividend date is Wednesday, February 14th. This represents a $0.18 annualized dividend and a dividend yield of 0.27%. MAXIMUS’s dividend payout ratio (DPR) is currently 5.36%.
TRADEMARK VIOLATION WARNING: “MAXIMUS, Inc. (MMS) Position Raised by Schwab Charles Investment Management Inc.” was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.dispatchtribunal.com/2018/02/14/schwab-charles-investment-management-inc-purchases-36570-shares-of-maximus-inc-mms.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.